MiMedx Group, Inc. , an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that the Company concluded a productive meeting with the Food and Drug Administration earlier today, October 28, 2013.
http://www.freshnews.com/news/862691/mimedx-reports-on-meeting-with-fda
http://www.freshnews.com/news/862691/mimedx-reports-on-meeting-with-fda
No comments:
Post a Comment